Examining preferences, utility values and cost-effectiveness for gemcitabine plus cisplatin (GEM/cis) for the treatment of bladder cancer — A discrete choice conjoint analysis conducted in Australia

✍ Scribed by P. Davey; N. Rajan; P. De Souza; J. Chen; M. Schulz

• Book ID: 117658450
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 192 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81085-6